{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:59:02Z","timestamp":1761562742198,"version":"3.41.2"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Lymphangioleiomyomatosis (LAM) is a rare systemic disease that generally leads to a progressive decline in pulmonary function. Experience, especially from the Asian population, including combined drug therapy before and after lung transplantation (LT) in LAM, is still limited. This study aimed to summarize the clinical data from patients with pulmonary LAM who underwent LT at centers in China.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A retrospective review of all patients with LAM undergoing LT at the two largest centers in China between 2010 and 2018 was conducted. Pre- and posttransplant data were assessed and analyzed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Overall, 25 patients with LAM underwent bilateral LT. The mean age was 35.0 \u00b1 8.6 years at diagnosis and 36.8 \u00b1 9.3 years at the time of transplant. Before LT, only six patients could complete pulmonary function test; the reachable mean forced expiratory volume in one second (FEV<jats:sub>1<\/jats:sub>) before LT was 15.9 \u00b1 6.9%. Twenty-one patients (84%) had a recurrent pneumothorax, four (16.0%) of which required pleurodesis. Eight patients (32%) were treated with sirolimus pretransplant for 3.9 years (1\u20139 years). The average intra-surgery bleeding volume was 1,280 \u00b1 730 ml in need of a transfusion of 1,316 \u00b1 874 ml due to moderate-to-severe adhesion and pretransplant pleurodesis. The causes of death of four patients (16%) included primary graft dysfunction, bronchial dehiscence with long-term use of sirolimus, and uncontrollable infections. The median follow-up time from LT was 41.1 \u00b1 25.0 months.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> LT for LAM patients from the Asian population has been reinforced from the data that we presented. Peri-transplantation use of sirolimus and LAM-related complications should be further defined and under constant surveillance.<\/jats:p>","DOI":"10.3389\/fmed.2021.584826","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T21:20:31Z","timestamp":1613683231000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["A Retrospective Study of Lung Transplantation in Patients With Lymphangioleiomyomatosis: Challenges and Outcomes"],"prefix":"10.3389","volume":"8","author":[{"given":"Ji","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingqing","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Ban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenguo","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1183\/09031936.00076209","article-title":"Review panel of the ERS LAM task force. European respiratory society guidelines for the diagnosis and management of lymphangioleiomyomatosis","volume":"35","author":"Johnson","year":"2010","journal-title":"Eur Respir J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.healun.2007.09.013","article-title":"Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM registry","volume":"26","author":"Maurer","year":"2007","journal-title":"J Heart Lung Transplant."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"National Institutes of Health Rare Lung Diseases Consortium; MILES Trial Group. Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"ATS\/JRS Committee on Lymphangioleiomyomatosis. Official American Thoracic Society\/Japanese Respiratory Society Clinical Practice Guidelines: lymphangioleiomyomatosis Diagnosis and Management","volume":"194","author":"McCormack","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13023-018-0946-8","article-title":"Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis","volume":"13","author":"Yoon","year":"2018","journal-title":"Orphanet J Rare Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1586\/17476348.2014.956728","article-title":"Should mammalian target of rapamycin inhibitors be stopped in women with lymphangioleiomyomatosis awaiting lung transplantation?","volume":"8","author":"El-Chemaly","year":"2014","journal-title":"Expert Rev Respir Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00408-012-9419-3","article-title":"Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry","volume":"191","author":"Oprescu","year":"2013","journal-title":"Lung."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.healun.2016.09.001","article-title":"International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant","volume":"35","author":"Yusen","year":"2016","journal-title":"J Heart Lung Transplant."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJM199610243351704","article-title":"Lung transplantation for lymphangioleiomyomatosis","volume":"335","author":"Boehler","year":"1996","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00005792-199909000-00004","article-title":"Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies \u201cOrphelines\u201d Pulmonaires (GERM\u201cO\u201dP)","volume":"78","author":"Urban","year":"1999","journal-title":"Medicine."},{"key":"B11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1053-2498(03)00195-5","article-title":"Lung transplantation for lymphangioleiomyomatosis","volume":"23","author":"Pechet","year":"2004","journal-title":"J Heart Lung Transplant."},{"key":"B12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/TP.0b013e31817c15df","article-title":"Lung transplantation for lymphangioleiomyomatosis: the French experience","volume":"86","author":"Reynaud-Gaubert","year":"2008","journal-title":"Transplantation."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.healun.2008.09.014","article-title":"Lung transplantation for lymphangioleiomyomatosis: the European experience","volume":"28","author":"Benden","year":"2009","journal-title":"J Heart Lung Transplant."},{"key":"B14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.transproceed.2010.12.051","article-title":"Lung transplantation for lymphangioleiomyomatosis: single-center Brazilian experience with no chylothorax","volume":"43","author":"Machuca","year":"2011","journal-title":"Transplant Proc."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.rmed.2015.08.014","article-title":"Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis","volume":"109","author":"Ussavarungsi","year":"2015","journal-title":"Respir Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.transproceed.2015.04.103","article-title":"Lung transplantation for lymphangioleiomyomatosis in a single Japanese institute, with a focus on late-onset complications","volume":"47","author":"Nakagiri","year":"2015","journal-title":"Transplant Proc."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0146749","DOI":"10.1371\/journal.pone.0146749","article-title":"Lung Transplantation for Lymphangioleiomyomatosis in Japan","volume":"11","author":"Ando","year":"2016","journal-title":"PLoS ONE."},{"key":"B18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/s0140-6736(84)90142-9","article-title":"Combined heart-and-lung transplantation for lymphangioleiomyomatosis","volume":"1","author":"Estenne","year":"1984","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.healun.2004.09.013","article-title":"The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis","volume":"24","author":"Kpodonu","year":"2005","journal-title":"J Heart Lung Transplant."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci USA."},{"key":"B21","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00408-017-0045-y","article-title":"Experience of lung transplantation in patients with lymphangioleiomyomatosis at a Brazilian reference centre","volume":"195","author":"Bruno","year":"2017","journal-title":"Lung."},{"key":"B22","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s00595-018-1678-z","article-title":"Single lung transplantation for lymphangioleiomyomatosis: a single-center experience in Japan","volume":"48","author":"Oishi","year":"2018","journal-title":"Surg Today."},{"key":"B23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.healun.2006.03.011","article-title":"Pulmonary Scientific Council Of The International Society For Heart And Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 update\u2014a consensus report from the pulmonary scientific council of the international society for heart and lung transplantation","volume":"25","author":"Orens","year":"2006","journal-title":"J Heart Lung Transplant."},{"key":"B24","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s11748-014-0418-6","article-title":"Japanese society of lung and heart\u2013lung transplantation. Registry of the Japanese society of lung and heart-lung transplantation: official Japanese Lung Transplantation Report, 2014","volume":"62","author":"Sato","year":"2014","journal-title":"Gen Thorac Cardiovasc Surg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.healun.2007.06.003","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007","volume":"26","author":"Trulock","year":"2007","journal-title":"J Heart Lung Transplant."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/j.1600-6143.2006.01276.x","article-title":"Development of the new lung allocation system in the United States","volume":"6","author":"Egan","year":"2006","journal-title":"Am J Transplant."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1097\/TP.0000000000001432","article-title":"Recent advances in mammalian target of rapamycin inhibitor use in heart and lung transplantation","volume":"100","author":"Fine","year":"2016","journal-title":"Transplantation."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.healun.2015.08.014","article-title":"The Registry of the International Society for Heart and Lung Transplantation: thirty-second Official Adult Lung and Heart-Lung Transplantation Report\u22122015; Focus Theme: Early Graft Failure","volume":"34","author":"Yusen","year":"2015","journal-title":"J Heart Lung Transplant."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1378\/chest.129.5.1274","article-title":"Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications","volume":"129","author":"Almoosa","year":"2006","journal-title":"Chest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.healun.2019.06.015","article-title":"Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis","volume":"38","author":"Khawar","year":"2019","journal-title":"J Heart Lung Transplant."},{"key":"B31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/1526924819835815","article-title":"Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis","volume":"29","author":"Salman","year":"2019","journal-title":"Prog Transplant."},{"key":"B32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/crj.13108","article-title":"Favorable survival even with high disease-specific complication rates in lymphangioleiomyomatosis after lung transplantation-long-term follow-up of a Japanese center","volume":"14","author":"Kurosaki","year":"2020","journal-title":"Clin Respir J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1056\/NEJM199011013231807","article-title":"Lymphangioleiomyomatosis. Clinical course in 32 patients","volume":"323","author":"Taylor","year":"1990","journal-title":"N Engl J Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1164\/ajrccm.151.2.7842216","article-title":"Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors","volume":"151","author":"Kitaichi","year":"1995","journal-title":"Am J Respir Crit Care Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","article-title":"NHLBI LAM Registry Group. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment","volume":"173","author":"Ryu","year":"2006","journal-title":"Am J Respir Crit Care Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"9454","DOI":"10.1074\/jbc.270.16.9454","article-title":"Rapamycin selectively blocks interleukin-2-induced proliferating cell nuclear antigen gene expression in T lymphocyte. Evidence for inhibition of CREB\/ATF binding activities","volume":"270","author":"Feuerstein","year":"1995","journal-title":"J Biol Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1164\/ajrccm.164.4.2101154","article-title":"Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex","volume":"164","author":"Moss","year":"2001","journal-title":"Am J Respir Crit Care Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.healun.2013.04.010","article-title":"Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation","volume":"32","author":"Ghassemieh","year":"2013","journal-title":"J Heart Lung Transplant."},{"key":"B39","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S1053-2498(03)00309-7","article-title":"Munich Lung Transplant Group. Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression","volume":"23","author":"Groetzner","year":"2004","journal-title":"J Heart Lung Transplant."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1097\/01.TP.0000064083.02120.2C","article-title":"Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation","volume":"75","author":"King-Biggs","year":"2003","journal-title":"Transplantation."},{"key":"B41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0020-7292(95)02619-3","article-title":"Pregnancy exacerbating unsuspected mediastinal lymphangioleiomyomatosis and chylothorax","volume":"52","author":"Brunelli","year":"1996","journal-title":"Int J Gynaecol Obstet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1164\/ajrccm.160.2.9901027","article-title":"Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment","volume":"160","author":"Johnson","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.rmed.2010.05.003","article-title":"Clinical analysis of patients with pulmonary lymphangioleiomyomatosis (PLAM) in mainland China","volume":"104","author":"Ye","year":"2010","journal-title":"Respir Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.584826\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T21:20:33Z","timestamp":1613683233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.584826\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":43,"alternative-id":["10.3389\/fmed.2021.584826"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.584826","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2021,2,16]]},"article-number":"584826"}}